Media Highlights
ASH recap: ‘Transformative’ advance in sickle cell disease, ‘breakthrough’ in AML and ALL
December 30, 2023
Dr. Mikkael A. Sekeres comments on the efficacy of reduced-intensity haploidentical-bone marrow transplants and says “the $1 million question” is figuring out how it compares to new gene therapies in terms of cost and effectiveness in this ASH 2023 recap.
